SwedenBIO - branschorganisationen för life science

Karo Pharma AB

Karo Pharma is a development company with a focus on broadening its activities to cover projects and products closer to market.

The company has several projects on the way to the clinical phase. Operations are conducted in Huddinge, Sweden and the share is listed on Nasdaq Stockholm. Karo Pharma’s projects focus on nuclear receptors as target proteins for the development of new pharmaceuticals. Several of the projects are based on new treatment principles and innovative compounds that are the first in class.


Kategorier: Biotech

Gå till Karo Pharma ABs hemsida